CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Overnight Digest: Stocks to watch out on June 4
DSIJ Intelligence
/ Categories: Trending, DSIJ News

Overnight Digest: Stocks to watch out on June 4

The stocks those are likely to witness significant movement on the bourses on June 4 are Eicher Motors, Cadila Healthcare, Tata Consultancy Services, Triveni Engineering & Industries and SMS Lifesciences.

Eicher Motors: The company and Volvo Group’s joint venture VE Commercial Vehicles has reported sales of 4,801 units in May 2019 as compared to 5,977 units in May 2018, recording decline of 19.7%. This includes 4,750 units of Eicher brand and 51 units of Volvo brand.

Cadila Healthcare: USFDA has concluded inspection at the company’s manufacturing facilities located at St. Louis, MO, USA of Nesher Pharmaceuticals LLC which is 100 per cent subsidiary of Zydus Pharmaceuticals USA. The inspection concluded with 3 observations at one facility and 8 observations at the other facility of Nesher Pharmaceuticals with a recommendation for Voluntary Action Indicated.

Tata Consultancy Services: The company has launched MasterCraft TransformPlus 4.0, a major upgrade of the product, with new cognitive features for analysis and modernisation of legacy applications.

Triveni Engineering & Industries: Company has received approval for buyback of fully paid up equity shares of the company having a face value of Rs 1 each equity shares, not exceeding 1 crore equity shares, representing 3.88 per cent of the paid up equity share capital of the company as at March 31, 2019, at a price of Rs. 100 per equity share payable in cash for an aggregate amount not exceeding Rs. 100 crore.

SMS Lifesciences India: The company has recommended a dividend of Rs. 1.50 (15 per cent) per equity share of Rs. 10  each, for the financial year ended March 31, 2019.

Previous Article Ceat signs PPA with Greenzest Solar
Next Article Ten stocks close to their 52-weeks low
Print
1903 Rate this article:
2.5
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR